Changes in patellofemoral and tibiofemoral joint cartilage damage and bone marrow lesions over 7 years: the multicentre osteoarthritis study by Stefanik, J et al.
Accepted Manuscript
Changes in Patellofemoral and Tibiofemoral Joint Cartilage Damage and Bone
Marrow Lesions over 7 Years: The Multicenter Osteoarthritis Study
Joshua J. Stefanik, MSPT, PhD, Assistant Professor Dr, Ali Guermazi, Dr, Frank W.
Roemer, Dr, George Peat, Dr, Jingbo Niu, Dr, Neil A. Segal, Dr, Cora E. Lewis, Dr,
Michael Nevitt, Dr, David T. Felson, Dr
PII: S1063-4584(16)01000-1
DOI: 10.1016/j.joca.2016.01.981
Reference: YJOCA 3692
To appear in: Osteoarthritis and Cartilage
Received Date: 21 October 2015
Revised Date: 21 December 2015
Accepted Date: 24 January 2016
Please cite this article as: Stefanik JJ, Guermazi A, Roemer FW, Peat G, Niu J, Segal NA, Lewis CE,
Nevitt M, Felson DT, Changes in Patellofemoral and Tibiofemoral Joint Cartilage Damage and Bone
Marrow Lesions over 7 Years: The Multicenter Osteoarthritis Study, Osteoarthritis and Cartilage (2016),
doi: 10.1016/j.joca.2016.01.981.
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to
our customers we are providing this early version of the manuscript. The manuscript will undergo
copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please
note that during the production process errors may be discovered which could affect the content, and all
legal disclaimers that apply to the journal pertain.
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
 
 1 
Changes in Patellofemoral and Tibiofemoral Joint Cartilage Damage and Bone Marrow 1 
Lesions over 7 Years: The Multicenter Osteoarthritis Study 2 
 3 
Joshua J. Stefanik1, 5, Ali Guermazi2, Frank W. Roemer2, 3, George Peat4, Jingbo Niu5, 4 
Neil A. Segal6,7, Cora E. Lewis8, Michael Nevitt9, and David T. Felson5 5 
 6 
1Department of Physical Therapy, Movement & Rehabilitation Sciences, Northeastern 7 
University, Boston, MA 8 
2Quantitative Imaging Center, Department of Radiology, Boston University School of 9 
Medicine, Boston, MA 10 
3Department of Radiology, University of Erlangen-Nuremberg, Erlangen, Germany 11 
4Research Institute for Primary Care and Health Sciences, Keele University, Keele, 12 
United Kingdom 13 
5Clinical Epidemiology Research and Training Unit, Boston University School of 14 
Medicine, Boston, MA 15 
6Department of Epidemiology, The University of Iowa, Iowa City, IA 16 
7Department of Rehabilitation Medicine, University of Kansas, Kansas City, KS 17 
8Department of Medicine, UAB, Birmingham, AB 18 
9Department of Epidemiology and Biostatistics, UCSF, San Francisco, CA 19 
 20 
Dr. Guermazi: ali.guermazi@bmc.org, Dr. Roemer: frank.roemer@klinikum-21 
augsburg.de, Dr. Peat: g.m.peat@keele.ac.uk, Dr. Niu: niujp@bu.edu, Dr. Segal: neil- 22 
nsegal@kumc.edu, Dr. Lewis: celewis@uabmc.edu, Dr. Nevitt: mnevitt@psg.ucsf.edu, 23 
Dr. Felson: dfelson@bu.edu 24 
 25 
Running title: Changes in PFJ and TFJ structural damage 26 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
 
 2 
 27 
Corresponding Author:   28 
 29 
Joshua Stefanik, MSPT, PhD  30 
Assistant Professor  31 
Department of Physical Therapy, Movement & Rehabilitation Sciences 32 
Northeastern University 33 
360 Huntington Avenue 34 
6B Robinson Hall 35 
Boston, MA 02115 36 
Office: 617-373-7954 37 
E-mail: j.stefanik@northeastern.edu 38 
 39 
 40 
 41 
 42 
 43 
 44 
 45 
 46 
 47 
 48 
 49 
 50 
 51 
 52 
 53 
 54 
 55 
 56 
 57 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
 
 3 
ABSTRACT 58 
Objectives: To investigate changes in cartilage damage and bone marrow lesions 59 
(BMLs) on MRI in the patellofemoral and tibiofemoral joints over 7 years.  60 
Methods: The Multicenter Osteoarthritis (MOST) Study is a cohort study of persons 61 
aged 50-79 years at baseline with or at high risk for knee osteoarthritis. Knees were 62 
eligible for the current study if they had knee MRI (1.0T) assessed for cartilage damage 63 
and BMLs at the baseline and 84-month visits. Knees were categorized as having MRI-64 
detected structural damage (cartilage and BMLs) isolated to the patellofemoral joint 65 
(PFJ), isolated to the tibiofemoral joint (TFJ), mixed or no damage at baseline and 84-66 
months. We determined the changes in PFJ and TFJ structural damage over 7 years 67 
and used logistic regression to assess the relation of baseline compartment distribution 68 
to incident isolated PFJ, isolated TFJ and mixed damage.  69 
Results: Among 339 knees that had full-thickness cartilage loss isolated to the PFJ or 70 
TFJ at baseline, only 68 (20.1%) developed full-thickness cartilage loss in the other 71 
compartment while 271 (79.9%) continued to only have the initial compartment affected. 72 
Compared to knees without full-thickness cartilage damage (n=582), those with isolated 73 
TFJ and PFJ full-thickness cartilage damage had 2.7 (1.5, 4.9) and 5.8 (3.6, 9.6) times 74 
the odds of incident mixed full-thickness cartilage damage, respectively. Similar results 75 
were seen when using other definitions of MRI-defined structural damage.  76 
Conclusions: Most knees with structural damage at baseline do not develop it in the 77 
other compartment. Knees that develop mixed structural damage are more likely to start 78 
with it isolated to the PFJ.  79 
 80 
KEYWORDS: knee osteoarthritis, MRI, pain 81 
 82 
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INTRODUCTION 83 
 84 
Knee osteoarthritis (OA) can occur in either the patellofemoral joint (PFJ), the 85 
tibiofemoral joint (TFJ) or both. Little is known about the natural history of knee OA in 86 
regards to the compartment where disease begins and whether it tends to remain 87 
isolated to one compartment or subsequently develops in the other compartment. 88 
Knowledge about where OA starts and progresses to include both the PFJ and TFJ will 89 
provide information on targets for early intervention and prevention of disease burden. 90 
For example, recent studies have demonstrated that taping and bracing of the PFJ may 91 
improve knee pain and BMLS [1-3]. Future work is warranted to determine how these 92 
non-invasive treatment strategies affect PFJ and TFJ joint structures over time. 93 
 94 
Duncan et al reported on the incidence, progression and sequence of development of 95 
radiographic OA in the PFJ and TFJ in symptomatic adults [4]. They concluded that OA 96 
starts in the PFJ with the development of TFJ OA over time. They proposed that 97 
isolated symptomatic PFJ OA may be a marker for future development of TFJ OA and 98 
thus a target for the early management of knee OA. A limitation of this study was the 99 
use of radiographs, which could have missed early changes in the OA disease process. 100 
To date, there are no published studies examining the natural history of OA 101 
development in the PFJ and TFJ evaluated by MRI, which is more sensitive than 102 
radiographs for identifying structural damage, in both the TFJ and PFJ [5]. MRI affords 103 
direct assessment of cartilage damage and bone marrow lesions (BMLs), which are 104 
hallmark structural features of OA [6]. Additionally, it is unknown if changes in the 105 
distribution of cartilage damage and BMLs in the PFJ and TFJ are related to changes in 106 
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knee pain. Because the experience of pain ultimately brings individuals to seek 107 
treatment, knowledge of how pain relates to structural changes in the PFJ and TFJ will 108 
ultimately help to prioritize how treatments are developed for knee OA to prevent 109 
disease burden. 110 
 111 
The purpose of this study was to investigate patterns of change in cartilage damage and 112 
bone marrow lesions (BMLs) in the patellofemoral and tibiofemoral joints over 7 years. 113 
Specifically, we describe which compartment tends to be involved first and whether 114 
disease that initially affects one compartment remains isolated or develops in the other 115 
compartment. A secondary aim was to investigate how changes in cartilage damage 116 
and BMLs among knee joint compartments relate to incident frequent knee pain. 117 
 118 
METHODS 119 
 120 
Study Sample: Knees for the current study were from participants in the Multicenter OA 121 
(MOST) Study. 3,026 participants were recruited from Iowa City, Iowa and Birmingham, 122 
Alabama. The MOST cohort consists of older adults that have or are at risk of 123 
developing knee OA. Some subjects had knee pain and radiographic OA (52% with 124 
Kellgren Lawrence grade ≥2) at baseline where others were at high risk for developing 125 
knee pain and OA based on being overweight, or having a history of knee injury or 126 
surgery. Subjects were ineligible if they had bilateral knee replacements or 127 
rheumatoid/other inflammatory arthritis [7].  128 
 129 
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MRI Acquisition: Knee MRIs were acquired at the baseline and 84-month visits. A 1.0 130 
Tesla extremity MRI system (OrthOneTM, ONI Medical Systems Wilmington, MA) was 131 
used with a phased array knee coil to obtain the following sequences [8, 9]: Fat-132 
suppressed fast spin echo intermediate weighted sequences in two planes, sagittal (TR 133 
4800 ms, TE 35 ms, 3 mm slice thickness, 0 mm interslice gap, 32 slices, 288 x 192 134 
matrix, 140 mm2 FOV, echo train length 8) and axial proton density weighted (TR 4680 135 
ms, TE 13 ms, 3 mm slice thickness, 0 mm interslice gap, 20 slices, 288 x 192 matrix, 136 
140 mm2 FOV, echo train length 8) and a STIR sequence in the coronal plane (TR 6650 137 
ms, TE 15 ms, TI 100 ms, 3 mm slice thickness, 0 mm interslice gap, 28 slices, 256 x 138 
192 matrix, 140 mm2 FOV, echo train length 8).  139 
 140 
Semi-quantitative MRI Assessment: In MOST, one randomly selected knee per 141 
individual was selected to be read for MRI features. Two musculoskeletal radiologists 142 
(FWR, AG) used the Whole-Organ Magnetic Resonance Imaging Score (WORMS) [10] 143 
to assess cartilage morphology and bone marrow lesions (BMLs) [8, 9] in fourteen 144 
regions in the PFJ and TFJ. Inter-reader weighted kappa values for WORMS scores 145 
ranged from 0.62-0.78 [9]. Any cartilage damage was defined as a WORMS score ≥2, 146 
full-thickness cartilage damage was defined by WORMS scores of 2.5, 5, or 6, which 147 
denotes focal full thickness defects, different degrees of diffuse full-thickness damage, 148 
respectively. Any size BML was defined as WORMS scores of ≥1. At baseline and 7-149 
year follow up, knees were categorized as having structural damage isolated to the PFJ, 150 
isolated to the TFJ, mixed (both PFJ and TFJ) or no damage in either compartment. We 151 
used three different definitions of structural damage: 1. Full-thickness cartilage damage 152 
(primary outcome), 2. Any cartilage damage, and 3.  Any BML (Figures 1 and 2).  153 
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 154 
We then created the following categories of change in the compartmental distribution of 155 
structural damage: no damage, isolated PFJ, isolated TFJ and mixed at both time points 156 
(no change); incident isolated TFJ, incident isolated PFJ and incident mixed damage. 157 
We further divided the incident mixed group into knees that had no damage, isolated 158 
PFJ and isolated TFJ damage at baseline.  159 
 160 
Frequent Knee Pain (FKP) Assessment: At the baseline and 84-month visits frequent 161 
knee pain was assessed in each knee by asking participants: “Do you have pain, aching 162 
or stiffness on most days of the month?” 163 
 164 
Statistical Analysis: We first described the change in compartmental distribution of 165 
structural damage over 7 years using the definitions described above and used logistic 166 
regression to assess the relation of baseline compartment distribution to incident 167 
isolated PFJ, isolated TFJ and mixed damage, adjusting for age, sex and BMI. We then 168 
determined the relation of change of compartment distribution of structural damage over 169 
7 years to incident frequent knee pain (knees were eligible if frequent knee pain was not 170 
present at baseline and present at 84-months) using logistic regression adjusting for 171 
age, sex and BMI. In sensitivity analyses we used a structural damage definition that 172 
required the presence of both cartilage damage and BMLs for a compartment to be 173 
considered to have structural damage. Results of this analysis were similar to the main 174 
analyses presented below and are not presented here. 175 
 176 
RESULTS 177 
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 178 
We restricted our analysis to knees that had knee MRI assessed for cartilage damage 179 
and BMLs at the baseline and 84-month study visits. In MOST one randomly selected 180 
knee from each subject who attended both the 60 and 84-month visits had their MRI 181 
read for cartilage damage and BMLs (n=1185 knees). Of these knees, 1012 and 762 182 
knees had complete MRI readings at the baseline and 84-month visits for cartilage 183 
morphology and BMLs, respectively (Figure 3). Due to resource restrictions there were 184 
less knees that had BMLs assessed. Age, sex and BMI distribution for the entire MOST 185 
cohort and those included in the current study are presented in Table 1. Since our focus 186 
was on the development of new disease findings in compartments initially unaffected or 187 
isolated to one compartment, we excluded knees that at baseline already had 188 
involvement of both the PFJ and TFJ (mixed damage). 592, 91 and 130 knees were 189 
removed with mixed any cartilage damage, full-thickness damage and BMLs, 190 
respectively. We also excluded 67 knees where BMLs regressed or changed their 191 
compartment involvement because there were too few knees in each pattern of change 192 
(Supplemental Table). This left 420, 921 and 565 knees eligible for the any cartilage 193 
damage, full-thickness cartilage damage and BML analyses, respectively.  194 
 195 
Figure 4 shows the changes in PFJ and TFJ full-thickness cartilage damage over 84 196 
months. The incidence of isolated PFJ, isolated TFJ and mixed full-thickness cartilage 197 
damage was 11.3, 13.9 and 5.3%, respectively. The remaining 69.3% did not develop 198 
full-thickness cartilage damage at follow-up. Among 339 knees that had full-thickness 199 
cartilage damage isolated to the PFJ or TFJ at baseline, only 68 (20.1%) developed full-200 
thickness cartilage damage in the other compartment while 271 (79.9%) continued to 201 
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only have the initial compartment affected with full-thickness cartilage damage. Among 202 
68 knees that started with isolated full-thickness damage in the PFJ or TFJ and 203 
developed full-thickness cartilage damage in the other compartment, 48 (70.6%) and 20 204 
(29.4%) started with isolated full-thickness damage in the PFJ and TFJ, respectively.  205 
 206 
Figure 5 shows the changes in PFJ and TFJ any cartilage damage over 84 months. The 207 
incidence of isolated PFJ, isolated TFJ and mixed any cartilage damage was 17.5, 28.2 208 
and 10.7%, respectively. The remaining 43.7% did not develop any cartilage damage at 209 
follow up. Among 317 knees that had any cartilage damage isolated to the PFJ or TFJ 210 
at baseline, 123 (38.8%) developed any cartilage damage in the other compartment 211 
while 194 (61.2%) continued to have only the initial compartment affected with any 212 
cartilage damage. Among 123 knees that started with isolated any damage in the PFJ 213 
or TFJ and developed any cartilage damage in the other compartment, 80 (65.0%) and 214 
43 (35.0%) started with isolated any cartilage damage in the PFJ and TFJ, respectively.  215 
 216 
Figure 6 shows the changes in PFJ and TFJ BMLs over 84 months. The incidence of 217 
isolated PFJ, isolated TFJ and mixed BMLs was 19.8, 15.5 and 7.3%, respectively. The 218 
remaining 57.3% did not develop a BML at follow up. Among 333 knees that had BMLs 219 
isolated to the PFJ or TFJ at baseline, only 96 (28.8%) developed BMLs in the other 220 
compartment while 237 (71.7%) continued to only have the initial compartment affected 221 
with BMLs. Among 96 knees that started with isolated BMLs in the PFJ or TFJ and 222 
developed a BML in the other compartment, 73 (76.0%) and 23 (24.0%) started with a 223 
BML in the PFJ and TFJ, respectively. 224 
 225 
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The relation of baseline compartment distribution to incident isolated PFJ, isolated TFJ 226 
and mixed damage is presented in Table 2. Compared to knees without full-thickness 227 
cartilage damage, those with isolated TFJ full-thickness cartilage damage had 2.7 (1.5, 228 
4.9) times the odds of incident mixed full-thickness cartilage damage and those with 229 
isolated PFJ full-thickness cartilage damage had 5.8 (3.6, 9.6) times the odds of 230 
developing mixed full-thickness cartilage damage. When directly comparing knees with 231 
baseline full-thickness damage in the TFJ to those with full-thickness damage in the 232 
PFJ,, those with isolated damage in the PFJ had 2.1 (1.2, 3.9) times the odds of 233 
developing mixed full-thickness cartilage damage (result not in table). Similar results 234 
were seen when using the any cartilage damage and any BML definition of structural 235 
damage. 236 
 237 
Of knees that developed full-thickness cartilage damage in PFJ and/or TFJ at 7 years, 238 
24% (38/158) reported the incidence of FKP at 7 years. The corresponding figure for 239 
those developing BMLs at 7 years was 19% (27/140). In general, after adjustment for 240 
age, gender, and baseline BMI, there were no strong associations between the pattern 241 
of incident structural damage (PFJ, TFJ or mixed) and incident FKP at 7 years (Table 242 
3). Additionally, there were low numbers of events to estimate the relationship between 243 
patterns of incident structural damage and incident FKP at 7 years, especially for the 244 
any cartilage damage definition. Knees that had developed incident isolated TFJ full-245 
thickness cartilage damage at 7 years had the highest rate of FKP at 7 years and this 246 
pattern was associated with a two-fold increase in the odds of incident FKP compared 247 
to knees that had no full-thickness cartilage damage at both time points (adjusted OR 248 
2.2 (1.2, 4.2)).  249 
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 250 
 251 
DISCUSSION 252 
 253 
Over 7 years of follow-up, full-thickness cartilage damage, any cartilage damage and 254 
BMLs developed in the other compartment in the knee when present in one 255 
compartment at baseline 20, 39 and 28% of the time (i.e., a majority of knees do not 256 
develop damage in the other compartment). Furthermore, most knees that developed 257 
mixed disease started with damage isolated to the PFJ. Our findings confirm previous 258 
radiographic data that have suggested that development of preventative and therapeutic 259 
strategies (i.e., taping, bracing, etc.) targeting the PFJ are warranted and may decrease 260 
the disease burden of knee OA [4].  261 
 262 
Most knees that had isolated structural damage in one compartment at baseline did not 263 
develop it in the other compartment over 7 years. This finding could reflect that certain 264 
individuals have risk factors for disease in one compartment and not the other. For 265 
example, those individuals that have stable isolated PFJ damage over time may have 266 
specific risk factors for PFJ OA (e.g., patella alta, trochlear dysplasia, PFJ 267 
malalignment, etc.). Additionally, we may speculate that PFJ and TFJ OA are distinct 268 
disease processes and mixed disease only occurs in those that either have risk factors 269 
for both PFJ and TFJ disease or have maladaptive compensations to disease in one 270 
compartment that contribute to increased risk for development of disease in the other 271 
compartment. Similarly, while we did not assess changes between the medial and 272 
lateral TFJ (our objective was to look at changes between the PFJ and TFJ), it is likely 273 
that medial and lateral TFJ OA are distinct disease processes and highly driven by 274 
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frontal plane alignment. This is evidenced by the relation of varus alignment to medial 275 
TFJ OA and the relation of valgus alignment to lateral TFJ OA. Furthermore, varus 276 
(valgus) alignment has protective relationship for lateral (medial) TFJ OA and it is likely 277 
that once you have medial or lateral TFJ OA the joint compartment affected will 278 
continue to progress and incident damage in the other compartment is less likely [11].  279 
 280 
While several studies have suggested OA may start in the PFJ, the current study is the 281 
first longitudinal study using MRI features of OA to address this question. Duncan 282 
reported isolated radiographic PFJ OA was more common than isolated TFJ OA (24% 283 
versus 4%) at baseline; over three years the incidence of isolated PFJ OA was more 284 
common than the incidence of isolated TFJ OA (17% versus 14%). Among those that 285 
developed incident mixed disease (n=55), 13 (24%), 32 (58%) and 10 (18%) started 286 
with no OA, isolated PFJ OA and isolated TFJ OA, respectively [4, 12]. In the 287 
Framingham study using various definitions of cartilage loss and BMLs, we found 288 
isolated PFJ damage was more common than isolated TFJ damage[13]. Sharma et al. 289 
found in knees without radiographic OA more knees with cartilage damage in the PFJ 290 
than the TFJ (47% versus 18%). In this study isolated PFJ BMLs were more common 291 
than isolated TFJ BMLs (34% versus 9%) [14]. The results of the current study are 292 
consistent with the findings of Duncan where mixed OA was most likely to start as 293 
isolated PFJ OA.  294 
 295 
If the disease process for mixed knee OA does start in the PFJ, treatment and 296 
prevention strategies that specifically target the PFJ are warranted. To date there is a 297 
lack of randomized controlled trials for treatments for PFJ OA.  The few randomized 298 
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controlled trials investigating interventions for PFJ OA have focused on bracing or 299 
taping interventions [2, 3, 15]. Patellofemoral pain is common in younger individuals and 300 
although cartilage or bone damage is not prevalent, these individuals have increased 301 
PFJ cartilage stress [16], bone strain [17] and bone water content [18, 19]. These 302 
abnormalities in the PFJ cartilage and bone may be a precursor to the development of 303 
OA in the PFJ. There is some suggestion in the literature that individuals with 304 
patellofemoral pain go on to develop PFJ OA [20-23]. Focusing prevention strategies in 305 
these individuals may decrease the burden of OA in the later years of their lives.  306 
 307 
In general we found no evidence of a strong relation between changes in the 308 
compartment distribution of structural damage and incident knee pain. This could be 309 
due to the fact that we only studied cartilage damage and BMLs and there are other 310 
features of OA on MRI that may be related to pain. However, we focused our analyses 311 
on cartilage damage and BMLs because we could specifically attribute them to the PFJ 312 
and TFJ. We are unaware of other studies that have investigated changes in 313 
compartment distribution of OA with changes in knee pain; however, other studies have 314 
investigated the presence of structural damage in knee compartments with incident 315 
knee pain/symptoms. Sharma and colleagues found that in knees without radiographic 316 
OA from the Osteoarthritis Initiative, cartilage damage (isolated PFJ and mixed) and 317 
BMLs (isolated PFJ and mixed) were associated with incident persistent symptoms [14]. 318 
The significance of these lesions in this population also confirms that the PFJ is 319 
important in the knee OA disease process. We also recognize that the use of pain 320 
medications could confound the association between joint damage and knee pain and is 321 
a recognized limitation of the current study. 322 
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 323 
There are limitations to our study. We recognize that there are other MRI features of OA 324 
that are relevant for disease incidence and progression (meniscal lesions, synovitis, 325 
joint effusion etc.) that we have not assessed. However, we cannot specifically attribute 326 
these features to the PFJ or TFJ. We also recognize that these features may also be 327 
related to the pain process in OA. However, the temporal relation of these features with 328 
cartilage damage and BMLs in the PFJ and TFJ is unknown and for this reason 329 
adjustment for these features would not be appropriate. We also did not adjust for 330 
additional potential mechanical risk factors for OA (e.g., meniscal lesions, frontal plane 331 
alignment, etc.) because our aim was not to identify risk factors for various patterns of 332 
knee OA over time. We assessed any cartilage damage, full thickness damage and 333 
BMLs as separate predictors but acknowledge that knees may have had both features 334 
present. Using a combined definition in sensitivity analyses we found similar results. We 335 
also recognize that not all individuals attended the 84-month visit or had MRI assessed 336 
at baseline and 84 months because of financial restrictions or total knee replacement 337 
and there may be differential loss to follow up in MOST. To address this we provided 338 
the age, sex and BMI for all baseline subjects and subjects included in our study (Table 339 
1) where we see a similar age, sex and BMI distribution. 340 
 341 
In summary, over 7 years of follow-up full-thickness cartilage damage, any cartilage 342 
damage and BMLs developed in the other compartment in the knee when present in 343 
one compartment at baseline 20, 39 and 28% of the time (i.e., a majority of knees do 344 
not develop damage in the other compartment). Furthermore, most knees that develop 345 
cartilage damage and BMLs in the other compartment start with damage isolated to the 346 
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PFJ, suggesting that mixed disease may begin in the PFJ. Prevention and treatment 347 
strategies targeting the PFJ are lacking and are needed to decrease the disease burden 348 
of knee OA.  349 
 350 
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Table 1.  Participant Characteristics 
 Overall 
MOST 
Cohort at 
baseline 
(n=3026) 
Knees 
included in 
cartilage 
analysis 
(n=1012) 
Knees included 
in BML* analysis 
(n=762) 
Age mean ± SD years 62.5 (8.1) 61.0 (7.5) 60.9 (7.4) 
Female (%) 60.2% 62.4% 61.3% 
BMI mean ± SD kg/m2  30.7 (6.0) 29.3 (4.5) 29.3 (4.6) 
*BML=bone marrow lesion 
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Table 2. Relation of baseline compartment status to follow-up compartment status  
  
MRI Feature 
  
Full-thickness 
cartilage damage 
Any cartilage damage Any BML 
Baseline 
Status 
Follow Up 
Status  
Incidence Adjusted 
OR* 
Incidence Adjusted 
OR* 
Incidence Adjusted 
OR* 
No 
damage 
 
Incident PFJ 
damage 
97/582 
(16.7%) 
Reference 29/103 
(28.2%) 
Reference 63/232 
(27.2%) 
Reference 
Isolated 
TFJ 
damage 
20/152 
(13.2%) 
0.80 
(0.47, 1.3) 
43/138 
(31.2%) 
1.2 
(0.65, 2.1) 
23/94 
(24.5%) 
0.84 
(0.48, 1.5) 
No 
damage 
 
Incident TFJ 
damage 
112/582 
(19.2%) 
Reference 40/103 
(38.8%) 
Reference 53/232 
(22.8%) 
Reference 
Isolated 
PFJ 
damage 
48/187 
(25.7%) 
1.3 
(0.89, 2.0) 
80/179 
(44.7%) 
1.2 
(0.75, 2.1) 
73/239 
(30.5%) 
1.3 
(0.86, 2.0) 
No 
damage 
 
 
Incident 
mixed 
damage 
31/582 
(5.3%) 
Reference 11/103 
(10.7%) 
Reference 17/232 
(7.3%) 
Reference 
Isolated 
PFJ 
damage 
48/187 
(25.7%) 
5.8 
(3.6, 9.6) 
80/179 
(44.7%) 
6.5 
(3.2, 13.1) 
73/239 
(30.5%) 
5.4 
(3.1, 9.7) 
Isolated 
TFJ 
damage 
20/152 
(13.2%) 
2.7 
(1.5, 4.9) 
43/138 
(31.2%) 
4.0 
(1.9, 8.4) 
23/94 
(24.5%) 
4.2 
(2.1, 8.4) 
*Adjusted for age, sex and BMI 
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Table 3. Relation of changes in compartment distribution of structural damage over 7 years to 
incident frequent knee pain (FKP). 
 
MRI Feature 
 
Any cartilage damage Full-thickness cartilage 
damage 
Any BML 
Pattern of 
change 
Incident 
FKP 
Adjusted 
OR* 
Incident 
FKP 
Adjusted 
OR* 
Incident 
FKP 
Adjusted 
OR* 
No damage 4/38 
(10.5%) 
Reference 50/319 
(15.7%) 
Reference 14/106 
(13.2%) 
Reference 
Incident 
isolated PFJ 
damage 
2/12 
(16.7%) 
1.6 
(0.26, 10.3) 
9/49 
(18.4%) 
1.1 
(0.50, 2.5) 
8/34 
(23.5%) 
1.9 
(0.71, 5.1) 
Incident 
isolated TFJ 
damage  
1/22 
(4.6%) 
0.4 
(0.04, 3.8) 
18/58 
(31.0%) 
2.2 
(1.2, 4.2) 
7/30 
(23.3%) 
1.7 
(0.61, 4.8) 
Incident 
mixed 
damage 
16/95 
(16.8%) 
1.5 
(0.48, 5.0) 
15/64 
(23.4%) 
1.5 
(0.78, 2.9) 
12/76 
(15.8%) 
0.9 
(0.38, 2.1) 
*Adjusted for age, sex and BMI 
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Supplemental Table. Patterns of BML 
Regression (n=67) 
 Frequency 
Isolated PFJ to Isolated TFJ 13 
Mixed to Isolated TFJ 9 
Isolated PFJ to None 12 
Isolated TFJ to None 11 
Mixed to None 1 
Isolated TFJ to Isolated PFJ 6 
Mixed to Isolated PFJ 15 
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FIGURE LEGENDS 513 
Figure 1. Isolated patello-femoral strucutral damage. A. Axial proton density-weighted 514 
image shows fissure-like full thickness defect at the lateral patellar facet (arrow). No 515 
additional structural damage was observed. B.Diiffuse and extensive but still isolated full 516 
thickness cartilage damage in the medial patellar facet is shown in this axial proton-517 
density-weighted image (arrows). 518 
 519 
Figure 2. Isolated early tibio-femoral structural damage. A. Coronal STIR image shows 520 
bone marrow lesion at the medial tibial plateau (short white arrows) with adjacent 521 
superficial focal cartilage lesion (long white arrow). In addition there is a small bone 522 
marrow lesion at the medial femur (gray arrow). B. Another example shows a superficial 523 
cartilage defect at the central medial femur (arrow). 524 
 525 
 526 
Figure 3. Knee eligibility flow chart. 527 
 528 
Figure 4. Changes in full-thickness cartilage damage in the patellofemoral and 529 
tibiofemoral joints over 84 months (n=921 knees). 530 
Figure 5. Changes in any cartilage damage in the patellofemoral and tibiofemoral joints 531 
over 84 months (n=420 knees). 532 
Figure 6.  Changes in BMLs in the patellofemoral and tibiofemoral joints over 84 months 533 
(n=565 knees). 534 
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762 eligible knees with bone marrow lesion scored in longitudinal MRI reading 
[61.3% female; Mean (sd) age and BMI 60.9 (7.4) and 29.3 (4.6)] 
3026 MOST Subjects at Baseline [60.2% female; Mean (sd) age and BMI 62.5 (8.1) 
and 30.7 (6.0)]  
2146 subjects attended 84-month clinic visit [60.8% female; Mean (sd) age and BMI 
61.8 (7.8) and 30.5 (5.8)] 
1185 subjects (one knee per subject) with baseline, 60- and 84-month longitudinal 
MRI reading [62.1% female; Mean (sd) age and BMI 61.1 (7.6) and 29.3 (4.6)] 
961 subjects without longitudinal MRI due to no MRI or 
quality of MRI [59.2% female; Mean (sd) age and BMI 62.5 
(7.9) and 32.0 (6.8)]  
 
1012 eligible knees with cartilage morphology scored in longitudinal MRI reading 
[62.4% female; Mean (sd) age and BMI 61.0 (7.5) and 29.3 (4.5)] 
 
880 subjects not coming to 84-month clinic visit  
[58.5% female; Mean (sd) age and BMI 64.3 (8.7) and 31.3 
(6.3)] 
 
173 knees with baseline or 84-month cartilage morphology 
not scored in some or all subregions 
423 knees with baseline or 84-month bone marrow lesion not 
scored in some or all subregions 
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